Ocular Therapeutix (OCUL) EBITDA Margin Growth (1y) (2015 - 2026)
Ocular Therapeutix (OCUL) EBITDA Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocular Therapeutix | 1.91 Bn | 1.91 Bn | 9.46 Mn | -26,799.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26,799.00 |
| Dec 31, 2025 | -23,041.00 |
| Sep 30, 2025 | -17,414.00 |
| Jun 30, 2025 | -23,744.00 |
| Mar 31, 2025 | -38,346.00 |
| Dec 31, 2024 | -16,061.00 |
| Sep 30, 2024 | -17,080.00 |
| Jun 30, 2024 | -12,968.00 |
| Mar 31, 2024 | -4,540.00 |
| Dec 31, 2023 | 209.00 |
| Sep 30, 2023 | 5,265.00 |
| Jun 30, 2023 | 2,691.00 |
| Mar 31, 2023 | -3,337.00 |
| Dec 31, 2022 | 909.00 |
| Sep 30, 2022 | -1,937.00 |
| Jun 30, 2022 | 1,028.00 |
| Mar 31, 2022 | 14,028.00 |
| Dec 31, 2021 | 4,852.00 |
| Sep 30, 2021 | 7,767.00 |
| Jun 30, 2021 | 96,719.00 |